טוען...
Death due to COVID‐19 in a patient with diabetes, epilepsy, and gout comorbidities
There is evidence of increased incidence, rapid progression, and poor prognosis of COVID‐19 in patients with underlying comorbidities such as diabetes and epilepsy. Developing effective treatment regimens for COVID‐19 patients with multiple comorbidities is crucial, as patients' past medical hi...
שמור ב:
| הוצא לאור ב: | Clin Case Rep |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753325/ https://ncbi.nlm.nih.gov/pubmed/33362925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3557 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|